Sign In
Buy NVO
$47.64
+0.230 (+0.485%)
At Close: Jun 25, 2026
Eli Lilly and Novo Want to Shake off Ozempic Copycats. Are They Ready To Meet Demand?
07:00am, Sunday, 17'th Nov 2024
The makers of Ozempic and Zepbound are fighting to stop compounded copies of their drugs. But it's unclear whether they can ramp up production enough.
Vaccine Maker Stocks Slump After RFK Jr. Nominated as HHS Head
12:55pm, Friday, 15'th Nov 2024
In the 2024 presidential election's latest impact on the stock markets, shares of several vaccine makers were down Friday morning following the nomination of Robert F. Kennedy Jr. to head the Departme
Novo Nordisk A/S (NVO) Price Prediction and Forecast 2025-2030
11:19pm, Thursday, 14'th Nov 2024
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs of slowing down, much to the delight of its Danish manufacturer, Novo Nord
Novo Nordisk says it is gradually phasing out human insulin pens globally
06:43am, Thursday, 14'th Nov 2024
Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp up manufacturing of its popular obesity and diabetes injections.
EU regulators quiz Novo Nordisk, Catalent rivals on $16.5 bln deal
12:43pm, Wednesday, 13'th Nov 2024
EU antitrust regulators have asked pharma rivals and customers for feedback in four business areas in light of Novo Holdings' planned $16.5 billion takeover of Catalent , people familiar with the matt
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
11:18am, Wednesday, 13'th Nov 2024
Bagsværd, Denmark, 13 November 2024 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
02:00pm, Tuesday, 12'th Nov 2024
Bagsværd, Denmark, 12 November 2024 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated
Here's Why Novo Nordisk (NVO) is a Strong Growth Stock
10:51am, Tuesday, 12'th Nov 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Novo Stock Has Been Slammed. How a New Weight-Loss Drug Could Boost Shares by 10%.
12:20pm, Monday, 11'th Nov 2024
Novo drug CagriSema, which combines semaglutide with cagrilintide, could help patients lose 25% of their body weight.
Novo Nordisk A/S (NVO) Price Prediction and Forecast 2025-2030
10:55am, Monday, 11'th Nov 2024
When it comes to weight loss drugs, Ozempic has become a phenomenon.
Novo Nordisk: Be Greedy When Others Are Fearful
07:30am, Monday, 11'th Nov 2024
Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong, with no signs of business deterioration. Despite Eli Lilly's underperformance in GLP-1 sales, Novo Nordi
Does This New Issue Threaten Eli Lilly and Novo Nordisk Shares?
05:45am, Sunday, 10'th Nov 2024
The good times aren't over, but the peak of the party might be passing.
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
04:22pm, Friday, 08'th Nov 2024
Bagsværd, Denmark, 8 November 2024 – This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated p
Novo Nordisk A/S - share repurchase programme
03:51pm, Friday, 08'th Nov 2024
Bagsværd, Denmark, 8 November 2024 – The execution of Novo Nordisk A/S' overall share repurchase programme for 2024 of DKK 20 billion continues. As part of this, Novo Nordisk A/S has now initiated
Novo Nordisk A/S purchases B shares worth DKK 4,736 million from Novo Holdings A/S under the 2024 share repurchase programme
03:47pm, Friday, 08'th Nov 2024
Bagsværd, Denmark, 8 November 2024 – Today, Novo Nordisk A/S has entered into an agreement to purchase 6,311,250 B shares of DKK 0.10 at a value of DKK 4,736,088,225.00 from Novo Holdings A/S. The
